Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Front Oncol. 2024 Mar 27;14:1351995. doi: 10.3389/fonc.2024.1351995. eCollection 2024.
Front Oncol. 2024.
PMID: 38601759
Free PMC article.
Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use.
Chiumente M, Rivano M, Severino D, Bertoli S, Gasbarro AR, Santeramo R, Pasqualini A, Provasi R, Mengato D, Palozzo AC.
Chiumente M, et al. Among authors: provasi r.
Eur J Hosp Pharm. 2023 Mar;30(e1):e112. doi: 10.1136/ejhpharm-2021-003157. Epub 2021 Dec 15.
Eur J Hosp Pharm. 2023.
PMID: 34911784
Free PMC article.
No abstract available.
Item in Clipboard
Pediatric blinatumomab preparation: Risk assessment on SmPC for software compliance.
Cirino M, Provasi R, Cebulec I, Palmieri C, Schincariol P, Zanon D.
Cirino M, et al. Among authors: provasi r.
J Oncol Pharm Pract. 2021 Oct;27(7):1674-1683. doi: 10.1177/1078155220966394. Epub 2020 Oct 27.
J Oncol Pharm Pract. 2021.
PMID: 33106105
Item in Clipboard
Cite
Cite